18 FDG positron emission tomography versus 67 Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma-Reference-Cited by-同舟云学术

18 FDG positron emission tomography versus 67 Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma

Published:2003-10-20 Issue:3 Volume:123 Page:454-462
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Zijlstra Josée M.,Hoekstra Otto S.,Raijmakers Pieter G. H. M.,Comans Emile F. I.,Van Der Hoeven Jacobus J.M.,Teule Gerrit J. J.,Jonkhoff A. Roelof,V Tinteren Harm,Lammertsma Adriaan A.,Huijgens Peter C.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2003.04617.x/fullpdf

Reference33 articles.

1. Role of 67Ga scintigraphy in localization of lymphoma;Van Amsterdam;Annals of Hematology,1996

2. The value of Ga-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in staging and monitoring the response of lymphoma to treatment;Bar-Shalom;Seminars in Nuclear Medicine,2001

3. Staging of thoracic lymphoma by radiological imaging;Bonomo;European Radiology,1997

4. Positron emission tomography for detection and staging of malignant lymphoma;Buchmann;Recent Results in Cancer Research,2000

5. Residual mass in lymphoma may not be residual disease;Canellos;Journal of Clinical Oncology,1988

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. INTRODUCTION TO MOLECULAR IMAGING;Drug Delivery Applications of Noninvasive Imaging;2013-09-20

2. Toxic Encephalopathy;Safety and Health at Work;2012-12

3. Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas – the PETAL trial;Leukemia & Lymphoma;2009-10-28

4. Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography for Interim Response Assessment of Advanced-Stage Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review;Journal of Clinical Oncology;2009-04-10

5. Comparison of gallium and PET scans at diagnosis and follow-up of pediatric patients with Hodgkin lymphoma;Pediatric Blood & Cancer;2008-08